Previous 10 | Next 10 |
BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022. Company management will host a corresponding...
Gainers: Option Care Health ( OPCH ) +8% . Bed Bath & Beyond ( BBBY ) +6% . Deciphera Pharmaceuticals ( DCPH ) +5% . GoodRx Holdings ( GDRX ) +4% . Redfin Corporation ( RDFN ) +4% . Losers: MIND Technology ( MINDP ...
SomaLogic (NASDAQ:SLGC) on Monday said it had signed a licensing agreement with Israel-based OncoHost for the development of precision cancer diagnostics. As per the agreement, OncoHost will license SLGC’s SomaScan Platform to develop proteomics tests for its PROphet diagnostic system,...
BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer t...
BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare Conference June 8-9, 2022, in New York 7th...
Gainers: Inotiv (NOTV) +41%. TScan Therapeutics (TCRX) +23%. SomaLogic (SLGC) +19%. Veru (VERU) +18%. Celularity (CELU) +17%. Losers: Opiant Pharmaceuticals (OPNT) -16%. Renovacor (RCOR) -15%. Embecta (EMBC) -7%. Wave Life Sciences (WVE) -5%. ...
SomaLogic, Inc. (SLGC) Q1 2022 Earnings Conference Call May 12, 2022 04:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Roy Smythe - CEO Shaun Blakeman - CFO Stephen Williams - CMO Conference Call Participants Brandon Couillard - Jefferies Daniel Brennan - Cowen Kyle Miks...
SomaLogic press release (NASDAQ:SLGC): Q1 GAAP EPS of -$0.02 beats by $0.15. Revenue of $22.98M (+21.8% Y/Y) misses by $0.22M. Based on ongoing strength in its business, SomaLogic is maintaining revenue guidance for the full year 2022 at a range of $105 million to $110 million, which represen...
BOULDER, Colo., May 12, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended March 31, 2022. “Our successful first quarter has kickstarted another exciting year for SomaLogic as w...
The NASDAQ is finally in formal bear market territory, although, as high growth investors fully know, we have been in a brutal bear market since at least November of 2021. My aggressive growth portfolio has not been spared the extreme pain; however, I am confident in my positions once...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...